GTEx AdiposeTissue 20-29 vs 50-59 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GTEx AdiposeTissue 20-29 vs 50-59 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GTEx AdiposeTissue 20-29 vs 50-59 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GTEx AdiposeTissue 20-29 vs 50-59 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GTEx AdiposeTissue 20-29 vs 50-59 Up.

Results found

Linked to

 

Label

Description

 

Gene

family with sequence similarity 30 member A

Gene

POU class 3 homeobox 3

Gene

double homeobox A pseudogene 8

Gene

p53 upregulated regulator of p53 levels

Gene

uncharacterized LOC339260

Gene

HOX transcript antisense RNA

Gene

embryonic stem cell related

Gene

HOXA11 antisense RNA

Gene

long non coding transcriptional activator of miR34a

Gene

uncharacterized LOC100192386

  • Gene

    family with sequence similarity 30 member A


  • Gene

    POU class 3 homeobox 3


  • Gene

    double homeobox A pseudogene 8


  • Gene

    p53 upregulated regulator of p53 levels


  • Gene

    uncharacterized LOC339260


  • Gene

    HOX transcript antisense RNA


  • Gene

    embryonic stem cell related


  • Gene

    HOXA11 antisense RNA


  • Gene

    long non coding transcriptional activator of miR34a


  • Gene

    uncharacterized LOC100192386

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.